Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Novick

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Cytokine|January 1, 1992
Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibodyD Novick, L M Shulman, L Chen, et al.
The Journal of Biological Chemistry|February 25, 1988
Two molecular forms of the human interferon-gamma receptor. Ligand binding, internalization, and down-regulationD G Fischer, D Novick, P Orchansky, et al.
Cytokine|October 12, 2000
Production of a biologically active human interleukin 18 requires its prior synthesis as PRO-IL-18B Liu, D Novick, S H Kim, et al.
Gene|October 10, 1997
Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2S H Kim, B Cohen, D Novick, et al.
Clinical Nephrology|December 3, 2003
Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failureG Lonnemann, D Novick, M Rubinstein, et al.
Hybridoma|February 1, 1991
Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand bindingD Novick, H Engelmann, M Revel, et al.
Journal of Pain Research|January 29, 2014
Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgiaX Peng, P Sun, D Novick, et al.
Cellular Immunology|May 1, 1985
Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferonD Aderka, D Novick, T Hahn, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 21, 2003
Financing health care in Europe: context for the Schizophrenia Outpatient Health Outcomes StudyM Knapp, D Novick, L Genkeer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 27, 2008
Predictors of the course of illness in outpatients with schizophrenia: a prospective three year studyJ M Haro, D Novick, D Suarez, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Cytokine|January 1, 1992
Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibodyD Novick, L M Shulman, L Chen, et al.
The Journal of Biological Chemistry|February 25, 1988
Two molecular forms of the human interferon-gamma receptor. Ligand binding, internalization, and down-regulationD G Fischer, D Novick, P Orchansky, et al.
Cytokine|October 12, 2000
Production of a biologically active human interleukin 18 requires its prior synthesis as PRO-IL-18B Liu, D Novick, S H Kim, et al.
Gene|October 10, 1997
Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2S H Kim, B Cohen, D Novick, et al.
Clinical Nephrology|December 3, 2003
Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failureG Lonnemann, D Novick, M Rubinstein, et al.
Hybridoma|February 1, 1991
Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand bindingD Novick, H Engelmann, M Revel, et al.
Journal of Pain Research|January 29, 2014
Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgiaX Peng, P Sun, D Novick, et al.
Cellular Immunology|May 1, 1985
Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferonD Aderka, D Novick, T Hahn, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 21, 2003
Financing health care in Europe: context for the Schizophrenia Outpatient Health Outcomes StudyM Knapp, D Novick, L Genkeer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 27, 2008
Predictors of the course of illness in outpatients with schizophrenia: a prospective three year studyJ M Haro, D Novick, D Suarez, et al.
Pageof 11